Family of anti-carcinoembryonic antigen chimeric antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 5, 1995
Grant Date -
N/A
app pub date -
Feb 16, 1993
filing date -
Feb 16, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention discloses novel chimeric monoclonal antibodies directed against human carcinoembryonic antigen, having antigen-specific variable regions. DNA constructs for the light and heavy chain variable regions comprising the novel antibodies of the invention are also disclosed. Eukaryotic host cells capable of expression of the chimeric antibodies and comprising the novel chimeric antibody-encoding DNA constructs are also described.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully